US Drug Recall Register
Class I · High risk Terminated Initiated Dec 20, 2018 (8 years ago)

Ceftriaxone for Injection USP

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

What was recalled

Ceftriaxone for Injection USP, 2 g, packaged in 10 Single Use Vials (NDC 68180-644-01) per box, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-644-10.

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-644-01
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0358-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ceftriaxone recalls

See all
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-098-01 D-0620-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-097-02 D-0619-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-096-02 D-0618-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-095-02 D-0617-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-094-02 D-0616-2023